Metformin's Surprising Benefits for Longevity and Diabetes
Metformin, primarily prescribed for type 2 diabetes, has recently shown promise as a potential longevity enhancer and p…
### Revlimid Price Gap: $900 in U.S., $0.37 in India
The price of Revlimid, a life-saving blood cancer drug, shows a vast disparity. In the U.S., it costs nearly $900 per p…
Revlimid Pricing: Why Cancer Pill Costs $900 in US, $0.37 in India
The cost of Revlimid, a crucial cancer treatment, soars to nearly $1,000 per daily capsule in the U.S. but can be as lo…
Gaddafi's UN Speech: A 2009 Critique of Pharmaceutical Profits
Muammar Gaddafi's 2009 UN speech delivered a critical critique against the pharmaceutical industry and the profit-drive…
Obesity Drug Market Set for 5x Growth by 2030, Reaching $77 Billion
The obesity drug market is anticipated to surge fivefold by 2030, reaching $77 billion, driven by escalating obesity ra…
Pharma R&D Investment: Oncology Leads Despite Heart Disease
Pharmaceutical research and development (R&D) investments are heavily concentrated in oncology, with nearly 10,000 drug…
Top Weight Loss Drugs: Market Share & Growth
The weight loss drug market, valued at $58 billion, is booming with Novo Nordisk and Eli Lilly leading the way. Their G…